Research animal retirement and lifetime care, now available through Alpha Genesis. Professionally managed lifetime care for retired research primates, with expert social reintroduction into stable outdoor groups led by veterinary staff deeply experienced in laboratory-animal medicine.
Learn moreSpecies
African green monkeys serve as an established NHP model in infectious disease, vaccine research, and virology programs. Alpha Genesis maintains colonies and supports program development for qualified sponsors, across North American and global development programs, at its AAALAC-accredited, USDA-licensed facilities.
Chlorocebus species, including the vervet and related subspecies, have a well-documented role in infectious-disease research, particularly for programs investigating SIV, hemorrhagic fever viruses, respiratory pathogens, and vaccine countermeasures. Their distinct immunological characteristics relative to macaque species provide complementary data in certain program contexts.
Alpha Genesis brings decades of primate program experience to its established African green monkey colonies, with the veterinary depth, behavioral management, and species-specific enrichment that complex infectious-disease work demands, because excellent welfare is fundamental to excellent science. The program supports animal supply and study-support engagements for government, academic, and pharmaceutical sponsors, including global development programs and studies designed to support international regulatory submissions, where appropriate, with documented colony health histories and animals available to research clients, scope confirmed during protocol review.
All engagements are subject to protocol qualification, IACUC approval, and applicable veterinary, regulatory, transportation, import/export, permitting, and animal-welfare requirements, and are available for research clients.
African green monkey programs at Alpha Genesis serve a focused set of research missions where this species provides scientific value.
Biodefense, countermeasure development, and pathogen research programs, including those requiring documented colony health status, biosafety compliance, and long-term program continuity.
Academic and government investigators studying viral pathogenesis, host-pathogen interactions, and natural-reservoir biology where African green monkeys provide a relevant study population.
Sponsors evaluating vaccine immunogenicity, protection, and correlates of immunity in a species with established precedent for specific infectious-disease endpoints, in support of North American and global development programs.
Organizations seeking long-term colony boarding, managed breeding, or contract colony services as part of sustained research infrastructure.
African green monkeys support specific research applications where the species’ biology and immunological profile provide scientific value not replicated in other NHP species.
Engagements can be structured as study support, animal supply, colony management, or combined programs. All are subject to scope qualification and regulatory requirements.
In-life study support for infectious disease, vaccine, and related research programs. Scope and GLP/non-GLP designation depend on protocol design and facility qualification at time of engagement.
Supply of health-screened African green monkeys to qualified sponsors or research facilities, and long-term colony-boarding services. Worldwide shipping and cross-border supply support are available for multinational sponsors, subject to all applicable veterinary, regulatory, and permitting requirements.
Contract breeding and colony development for sponsors requiring sustained supply or long-term research colony infrastructure for ongoing programs.
Compliance is expected; documented colony health and species-specific care are what set an infectious-disease primate program apart. That veterinary and welfare depth underpins data reliability for African green monkey work, with accreditation and oversight as backing.
Alpha Genesis has maintained African green monkey colonies as part of its NHP program, providing sponsors with access to animals with documented health histories and experienced colony management.
Experience supporting infectious disease and vaccine research programs with appropriate biosafety practices, documented health status, and study-support capabilities.
Colony boarding, managed breeding, and long-term program structures are available for sponsors requiring sustained research infrastructure beyond single study engagements.
Accreditation and registration are the baseline; what sets the program apart is documented colony health and biosafety discipline. AAALAC-accredited and USDA-licensed operations, OLAW-assured and backed by IACUC oversight, give sponsors audit-ready records, consistent with internationally recognized GLP expectations, that hold up to regulatory review for global development programs.
Continuous veterinary monitoring and species-appropriate welfare practices, enrichment, social management, and behavioral care, protect both animal wellbeing and the scientific value of research programs.
Early-stage consultation support for sponsors designing new programs involving African green monkeys, including study design input, feasibility assessment, and scope qualification.
Yes. Alpha Genesis supplies African green monkeys to qualified external research facilities in North America and worldwide, with full veterinary, regulatory, transportation, import/export, permitting, and animal-welfare documentation. Cross-border supply for multinational programs can be arranged. Animals are available for qualified programs. Contact us to confirm cohort requirements and logistics.
Whether you are planning a new infectious disease study, seeking colony support, or developing a long-term research infrastructure, our team is available to discuss scope and feasibility.
